HIGH-DOSE RADIOIMMUNOTHERAPY OF RELAPSED B-CELL LYMPHOMAS

被引：0
|
作者：
PRESS, OW
机构：
[1] UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195
[2] FRED HUTCHINSON CANC RES CTR,SEATTLE,WA 98104
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1995年 / 210卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：11 / NUCL
相关论文
共 50 条
  • [41] High-dose [131I]tositumomab (anti-CD20) radioimmunotherapy and autologous hematopoietic stem-cell transplantation for adults ≥60 years old with relapsed or refractory B-cell lymphoma
    Gopal, Ajay K.
    Rajendran, Joseph G.
    Gooley, Ted A.
    Pagel, John M.
    Fisher, Darrell R.
    Petersdorf, Stephen H.
    Maloney, David G.
    Eary, Janet F.
    Appelbaum, Frederick R.
    Press, Oliver W.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (11) : 1396 - 1402
  • [42] Poor survival with high-dose chemotherapy and autologous stem cell support in double-hit and double-expressor B-cell lymphomas
    Reagan, Patrick M.
    Friedberg, Jonathan W.
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S249 - S253
  • [43] COMPARISON OF HIGH-DOSE THERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR T-CELL AND B-CELL NON-HODGKINS-LYMPHOMAS
    VOSE, JM
    PETERSON, C
    BIERMAN, PJ
    WEISENBURGER, DD
    LINDER, J
    HARRINGTON, D
    VAUGHAN, WP
    KESSINGER, A
    ARMITAGE, JO
    BLOOD, 1990, 76 (02) : 424 - 431
  • [44] Immuno-chemotherapy with rituximab followed by high-dose therapy and autologous stem cell transplantation as treatment of advanced B-cell lymphomas in children
    Dyshlevaya, ZM
    Shelikhova, LS
    BONE MARROW TRANSPLANTATION, 2006, 37 : S243 - S243
  • [45] Low Dose Versus High Dose Radiation Therapy for Indolent Primary Cutaneous B-Cell Lymphomas
    Goyal, A.
    Carter, J.
    Pashtan, I. M.
    Gallotto, S.
    Niemierko, A.
    Ng, A. K.
    Winkfield, K. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E455 - E455
  • [46] Comparing Efficacy of Intrathecal Chemotherapy versus High-Dose Methotrexate for Central Nervous System Prophylaxis in High-Grade B-Cell Lymphomas
    Ianniello, Nicole
    Sandoval-Sus, Jose
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S384 - S384
  • [47] Low- versus high-dose radioimmunotherapy with humanized anti-CD20 antibodies in a broad spectrum of B-cell associated maligancies
    Behr, TM
    Wörmann, B
    Gramatzki, M
    Béhé, M
    Griesinger, F
    Hiddemann, W
    Goldenberg, DM
    Becker, W
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (09): : 970 - 970
  • [48] HIGH-DOSE POLYCHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN CHILDREN WITH RELAPSED LYMPHOMAS
    HARTMANN, O
    PEIN, F
    BEAUJEAN, F
    KALIFA, C
    PATTE, C
    PARMENTIER, C
    LEMERLE, J
    JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (09) : 979 - 985
  • [49] Update on CAR T-Cell Therapies for Relapsed/Refractory B-Cell Lymphomas
    Schuster, Stephen J.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (5.5): : 622 - 624
  • [50] Combination of rituximab with dose-intensified CHOP (double-CHOP) followed by high-dose chemotherapy for high risk diffuse large B-cell lymphomas (DLBL)
    Yamazaki, T
    Sawada, U
    Kura, Y
    Ito, T
    Hatta, Y
    Takeuchi, J
    Takei, K
    Uenogawa, K
    Saiki, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 603S - 603S
12345